Results 31 to 40 of about 518,498 (229)

Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics [PDF]

arXiv, 2023
Cancer is one of the most widespread diseases around the world with millions of new patients each year. Bladder cancer is one of the most prevalent types of cancer affecting all individuals alike with no obvious prototypical patient. The current standard treatment for BC follows a routine weekly Bacillus Calmette-Guerin (BCG) immunotherapy-based ...
arxiv  

Evaluation of MMP‑2, MMP‑9, TIMP‑1, TIMP‑2, NGAL and MMP‑9/NGAL complex in urine and sera from patients with bladder cancer [PDF]

, 2015
The identification of biomarkers in urine or serum samples from patients with bladder cancer is urgently required for the development of non-invasive methods for the diagnosis of bladder carcinoma and to facilitate follow-up surveillance, to combat the ...
Bruzzese, Dario, DI CARLO, Angelina, Ricci, Serena   +2 more
core   +1 more source

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma [PDF]

, 2013
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their low abundance in a complex background. Altered gene expression in tumours may not reflect protein levels in body fluids.
A Martin, BM Bolstad, C Parr, C Parr, C Wang, C Yu, D G Ward, D Kaufman, D Tilki, E Cauberg, E Orenes-Piñero, Gordon K Smyth, H Kataoka, H Kawanishi, H Onda, I Waldhauer, J Salo, J Wiśniewski, K Chang, K K Cheng, K Nakamura, L Dyrskjøt, L Mengual, M Babjuk, M Grønborg, M Lindén, M Makridakis, M Muramaki, M P Zeegers, M Sánchez-Carbayo, M Volmer, M Yang, MP Zeegers, N Anderson, N D James, N J Shimwell, N James, N Nagaraj, N Yang, O Nagakawa, P J Johnson, R Bryan, R T Bryan, RA Irizarry, S Ikematsu, S Irmak, S Kageyama, S Ray, S Shariat, T O’Brien, W Wei, Y Chang, Y Chen, Y Lotan, Y Senga   +54 more
core   +6 more sources

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. [PDF]

, 2010
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which ...
Aben, Katja K, Albanes, Demetrius, Allen, Naomi E, Allione, Alessandra, Andriole, Gerald, Baris, Dalsu, Benhamou, Simone, Besenbacher, Soren, Bishop, David T, Black, Amanda, Bolick, Sophia CE, Brennan, Paul, Bueno-de-Mesquita, H Bas, Burdett, Laurie, Cancel-Tassin, Geraldine, Canzian, Federico, Caporaso, Neil, Carrato, Alfredo, Chanock, Stephen J, Chatterjee, Nilanjan, Chen, Meng, Clavel-Chapelon, Francoise, Cortessis, Victoria K, Cussenot, Olivier, Czerniak, Bogdan, D García-Prats, María, De Vivo, Immaculata, Dietrich, Holger, Dinney, Colin P, Diver, W Ryan, Figueroa, Jonine D, Fletcher, Tony, Fraumeni, Joseph F, Fu, Yi-Ping, Gago-Dominguez, Manuela, Gapstur, Susan M, Garcia-Closas, Montserrat, García-Closas, Reina, Godfrey, Ashley, Golka, Klaus, Grubb, Robert, Guarrera, Simonetta, Gurzau, Eugen, Hengstler, Jan G, Hildebrandt, Michelle AT, Hoover, Robert N, Hunter, David J, Hutchinson, Amy, Jacobs, Eric J, Jacobs, Kevin B, Johnson, Alison, Karagas, Margaret R, Kiemeney, Lambertus A, Kiltie, Anne E, Knowles, Margaret A, Kogevinas, Manolis, Koppova, Kvetoslava, Kumar, Rajiv, Landi, Maria Teresa, Ljungberg, Borje, Lloreta, Josep, Makkinje, Remco R, Malats, Nuria, Matullo, Giuseppe, Mayordomo, Jose I, McGrath, Monica, Navarro, Carmen, Panico, Salvatore, Pike, Malcolm C, Polidoro, Silvia, Porru, Stefano, Prokunina-Olsson, Ludmila, Purdue, Mark P, Rafnar, Thorunn, Real, Francisco X, Riboli, Elio, Ricceri, Fulvio, Rothman, Nathaniel, Rudnai, Peter, Sacerdote, Carlotta, Sanchez, Manuel, Sanz-Velez, José I, Schned, Alan, Schwenn, Molly, Selinski, Silvia, Serra, Consol, Silverman, Debra T, Stefansson, Kari, Stern, Mariana C, Sulem, Patrick, Tardón, Adonina, Taylor, Jack A, Teo, Mark TW, Thun, Michael, Tjonneland, Anne, Trichopoulos, Dimitrios, Valdivia, Gabriel, Van Den Berg, David, Vermeulen, Sita H, Vineis, Paolo, Virtamo, Jarmo, Wang, Zhaoming, Weinstein, Stephanie J, Wheeler, William, Witjes, J Alfred, Wu, Xifeng, Xu, Zongli, Yang, Hushan, Yeager, Meredith, Yuan, Jian-Min   +109 more
core   +2 more sources

Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study [PDF]

, 2014
Background: There is evidence that cancer survivors are at increased risk of second primary cancers. Changes in the prevalence of risk factors and diagnostic techniques may have affected more recent risks.<p></p> Methods: We examined the
A Chopra, A Mehnert, Aishah Coyte, C Dong, C Fabbri, C Thellenberg, CH Johnson, D Brewster, D Brewster, D Brewster, D Forman, D Groheux, D Howel, David S Morrison, DM Parkin, DM Parkin, DR Youlden, E Crocetti, E Kellen, EM Ibrahim, F Levi, GB Yang, I Soerjomataram, IARC/ENCR/IACR Working Group, International Agency for Research on Cancer, J Ferlay, J Jegu, J Maddams, JA Atienza, JW Hotchkiss, K Hemminki, K Hemminki, K Moser, L Liu, L Liu, L Mellemkjaer, LJ Rutten, MB Adamo, MH Schmid-Wendtner, Philip McLoone, RE Curtis, S Scholes, X Gao, Y Chen   +43 more
core   +3 more sources

A general two-stage progressive model of cancer natural history to project downstaging due to multi-cancer screening tests [PDF]

arXiv, 2023
Multi-cancer early detection (MCED) tests offer to screen for multiple types of cancer with a single blood sample. Despite their promising diagnostic performance, evidence regarding their population benefit is not yet available. Expecting that benefit will derive from detecting cancer before it progresses to an advanced stage, we develop a general two ...
arxiv  

Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer [PDF]

, 2016
The NCI Bladder Cancer Task Force convened a Clinical Trials Planning Meeting (CTPM) Workshop focused on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer (NMIBC).
Abrams, Acquaviva, Apolo, Apolo, Atkins, Babjuk, Balbas-Martinez, Berman, Blackburn, Boorjian, Bracci, Brahmer, Brausi, Buchwald, Callahan, Callahan, Champiat, Chen, Cheng, Cheng, Choi, Damrauer, Dash, Delyon, di Martino, Dinney, Drake, Dummer, Emens, Epstein, Freeman, Galluzzi, Garon, Ghasemzadeh, Gofrit, Golden, Goldman, Gospodarowicz, Gray, Gray, Gui, Gulley, Guo, Hammers, Hansel, Harland, Herbst, Herrera-Abreu, Hodi, Hyman, Inman, Iyer, Jarow, Jarow, Kamat, Kandimalla, Kim, Kim, Kitano, Knowles, Kompier, Ku, Lamm, Lamm, Lamm, Lamont, Larkin, Lee, Lerner, Lerner, Liu, Mak, Malmstrom, McConkey, McShane, McShane, Morales, Motzer, Patschan, Plimack, Powles, Quilty, Redman, Redman, Rizvi, Robert, Robert, Sanchez-Carbayo, Sargent, Selby, Sharabi, Sharabi, Sjodahl, Skinner, Snyder, Spranger, Srivastava, Steinberg, Taube, Tomlinson, Topalian, Topalian, Tumeh, Van Allen, Van Allen, Weber, Weiss, Williams, Witjes, Wo, Wolchok, Wolchok, Woo, Yang, Zhang   +114 more
core   +3 more sources

An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer [PDF]

, 2017
Objectives: Our goal is to determine the ability of multi-parametric magnetic resonance imaging (mpMRI) to differentiate muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC).
Barchetti, Giovanni, Carano, Davide, Catalano, Carlo, Catto, James, DE BERARDINIS, Ettore, DEL MONTE, Maurizio, Gallucci, Michele, Grompone, Marcello Domenico, Leonardo, Costantino, Panebianco, Valeria, Simone, Giuseppe   +10 more
core   +1 more source

Focus on bladder cancer [PDF]

Cancer Cell, 2004
Supported by NIH Specialized Programs of Research Excellence Grant in Genitourinary Cancer CA91846, and National Cancer Institute Grants CA16672, CA066723, and CA85078.
Anita L. Sabichi, Bogdan Czerniak, Arlene O. Siefker-Radtke, Colin P.N. Dinney, Xifeng Wu, David J. McConkey, Liana Adam, H. Barton Grossman, Randall E. Millikan, Ashish M. Kamat, William F. Benedict, Tomasz Tuziak, Menashe Bar-Eli   +12 more
openaire   +3 more sources

Investigation Toward The Economic Feasibility of Personalized Medicine For Healthcare Service Providers: The Case of Bladder Cancer [PDF]

arXiv, 2023
In today's complex healthcare landscape, the pursuit of delivering optimal patient care while navigating intricate economic dynamics poses a significant challenge for healthcare service providers (HSPs). In this already complex dynamics, the emergence of clinically promising personalized medicine based treatment aims to revolutionize medicine.
arxiv